Kuttesch J F, Nelson J A
Cancer Chemother Pharmacol. 1982;8(2):221-9. doi: 10.1007/BF00255488.
In a child lacking adenosine deaminase and in patients treated with deoxycoformycin (a potent inhibitor of the enzyme), apparent renal secretion of 2'-deoxyadenosine (dAdo) and reabsorption of adenosine (Ado) were observed. The renal clearance of dAdo in humans was approximately five-fold that of creatinine, whereas the renal clearance of Ado was only one-fifth that of creatinine. In mice treated with deoxycoformycin, a similar paradigm was observed. Specifically, plasma levels of Ado and dAdo were elevated to detectable levels and apparent renal secretion and reabsorption of these purine nucleosides became manifest. Thus, the mouse may serve as a suitable model to study the renal handling of these two compounds. The active renal secretion of dAdo may occur because the compound has not been appreciably synthesized by mouse kidney in situ, and 'ion-trapping' of dAdo in acid urine could not explain the net secretion. The differential transport of these similar purine nucleosides suggests a very selective transport system in mammalian kidney. Although carrier-mediated, facilitated diffusion of purine nucleosides across cell membranes is a well-known ph enomenon, the present data indicate the existence of (an) active transport system(s) for the transepithelial secretion of dAdo, and possibly for the reabsorption of Ado.
在缺乏腺苷脱氨酶的儿童以及用脱氧助间型霉素(该酶的一种强效抑制剂)治疗的患者中,观察到了2'-脱氧腺苷(dAdo)明显的肾脏分泌以及腺苷(Ado)的重吸收。人类中dAdo的肾脏清除率约为肌酐清除率的五倍,而Ado的肾脏清除率仅为肌酐清除率的五分之一。在用脱氧助间型霉素治疗的小鼠中,观察到了类似的模式。具体而言,Ado和dAdo的血浆水平升高至可检测水平,并且这些嘌呤核苷明显的肾脏分泌和重吸收变得明显。因此,小鼠可能是研究这两种化合物肾脏处理情况的合适模型。dAdo的活跃肾脏分泌可能发生,因为该化合物并未在小鼠肾脏原位大量合成,并且dAdo在酸性尿液中的“离子捕获”无法解释净分泌。这些相似嘌呤核苷的差异转运表明哺乳动物肾脏中存在非常选择性的转运系统。尽管嘌呤核苷通过载体介导的易化扩散穿过细胞膜是一种众所周知的现象,但目前的数据表明存在用于dAdo跨上皮分泌以及可能用于Ado重吸收的主动转运系统。